4.8 Article

Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma

Related references

Note: Only part of the references are listed.
Article Immunology

Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer

Xin Qing et al.

Summary: This study systematically assessed the association between angiogenesis and gastric cancer (GC). The authors identified two molecular subtypes and determined the correlation between angiogenesis-associated genes mutations, clinicopathological characteristics, prognosis, immune cell infiltration, and tumor microenvironment. They established an AAG_score for predicting overall survival (OS) and created a reliable nomogram for clinical viability. The study provides insights into the characteristics of TME and potential immunotherapy strategies in GC.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer

Guoming Chen et al.

Summary: GPC2 shows high expression in most cancers, providing early diagnostic value and correlation with prognosis. It is also significantly associated with immune cell infiltration and DNA methylation, indicating its potential role in tumorigenesis and tumor immunity.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration

Zhengguang Wang et al.

Summary: This study investigates the role of pyroptosis-related long non-coding RNAs (lncRNAs) in predicting the diagnosis and prognosis of gastric adenocarcinoma. The study establishes a lncRNA signature associated with pyroptosis as a prognostic tool and evaluates their immune value. The findings suggest that these lncRNAs can effectively guide the prognosis and immune microenvironment in gastric adenocarcinoma patients.

FRONTIERS IN IMMUNOLOGY (2022)

Article Cell Biology

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma

Gang Wang et al.

Summary: By constructing a model with angiogenesis-related genes, this study identified key genes, established a risk score model that can predict treatment response and prognosis, which is of great significance for the treatment and prognosis of GBM.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Genetics & Heredity

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma

Binfeng Liu et al.

Summary: The novel CRLncSig identified in this study can serve as a promising predictor for prognosis, immune activity, tumor immune microenvironment, immune response, and chemotherapeutic drug susceptibility in patients with soft tissue sarcoma (STS).

FRONTIERS IN GENETICS (2022)

Article Genetics & Heredity

A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas

Binfeng Liu et al.

Summary: In this study, a novel signature consisting of seven necroptosis-related lncRNAs (NRlncRNAs) was successfully established for soft tissue sarcoma (STS) patients. The signature showed stable prediction performance and general applicability in predicting prognosis, tumor immunogenicity, and therapeutic response in STS.

FRONTIERS IN GENETICS (2022)

Article Endocrinology & Metabolism

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma

Binfeng Liu et al.

Summary: In this study, a novel signature consisting of four lncRNAs related to cuproptosis was identified and found to effectively evaluate the prognosis, tumor immune microenvironment, and immunotherapy response in osteosarcoma (OS).

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Pathology

The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities

Joon Hyuk Choi et al.

Summary: Soft tissue tumors are rare and diagnostically challenging neoplasms that require accurate diagnosis for proper treatment and prognosis. The 5th Edition of the 2020 WHO classification of tumors of soft tissue and bone incorporates significant advances in molecular biology and diagnostic criteria, emphasizing the increasing reliance on molecular characteristics for tumor classification.

ADVANCES IN ANATOMIC PATHOLOGY (2021)

Review Oncology

Macrophage-Based Approaches for Cancer Immunotherapy

Nicholas R. Anderson et al.

Summary: Adoptive cell therapy with genetically modified T cells has shown promising results in hematologic malignancies, but applying it to solid tumors has been challenging. This has led to the investigation of alternative immune cells as therapeutic options. Macrophages have functional plasticity that can be harnessed for both antitumor and protumor effects, leading to efforts to deplete or repolarize tumor-associated macrophages, as well as exploring the potential of adoptively transferring genetically modified macrophages.

CANCER RESEARCH (2021)

Article Genetics & Heredity

Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway

Xinxin Zhang et al.

Summary: The study showed that NCAPG overexpression in CA can enhance EMT and suppress tumor cell apoptosis by activating Wnt/beta-catenin signaling pathway.
Article Immunology

Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma

Miaosen Zheng et al.

Summary: The study showed that AHNAK2 gene is significantly overexpressed in LUAD tumor tissues and serves as an independent prognostic indicator for LUAD patients. AHNAK2 expression is associated with disease stage, differentiation, tumor size, and lymph node metastasis. Furthermore, AHNAK2 expression is related to specific immune cell infiltrates in the tumor microenvironment.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Immunology

AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis

Long Zheng et al.

Summary: AHNAK2 is identified as a key gene in papillary thyroid cancer, its upregulation is associated with advanced tumor grades and stages, poor overall survival, as well as immune cell infiltration. AHNAK2 may serve as a novel prognostic marker for PTC.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Engineering, Biomedical

Management of tumor growth and angiogenesis in triple-negative breast cancer by using redox nanoparticles

Babita Shashni et al.

Summary: The study reveals that antioxidants play a crucial role in inhibiting tumor growth, particularly the original antioxidant nanoparticles show significant therapeutic effects on triple-negative breast cancer. Additionally, antioxidants limit tumor progression by downregulating the ROS-regulated angiogenesis inducer VEGF in breast cancer cells and endothelial cells.

BIOMATERIALS (2021)

Article Cell Biology

The overexpression of Tipe2 in CRC cells suppresses survival while endogenous Tipe2 accelerates AOM/DSS induced-tumor initiation

Yan Li et al.

Summary: Tipe2 may have a dual function in regulating cellular senescence, suppressing tumor cell proliferation and survival while promoting tumorigenesis initiation under exposure to dangerous environments such as AOM/DSS-related inflammation.

CELL DEATH & DISEASE (2021)

Article Oncology

The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma

Lijiang He et al.

Summary: This study developed a novel predictive signature for chemotherapy response in osteosarcoma patients by analyzing immune cell infiltration and gene expression profiles. High-level immune infiltration was associated with good responders, and a panel of five IRGs was identified as predictive for chemotherapy response. The predictive signature showed accuracy of 0.832 for the training cohort and 0.720 for the validation cohort, suggesting its potential for improving chemotherapy efficacy in osteosarcoma patients.

BMC CANCER (2021)

Article Oncology

FILIP1L Loss Is a Driver of Aggressive Mucinous Colorectal Adenocarcinoma and Mediates Cytokinesis Defects through PFDN1

Mijung Kwon et al.

Summary: The study identifies FILIP1L as a tumor suppressor in mucinous colon cancer and demonstrates that FILIP1L loss leads to abnormal stabilization of a centrosome-associated chaperone protein, driving aneuploidy and disease progression.

CANCER RESEARCH (2021)

Article Multidisciplinary Sciences

The P-type ATPase transporter ATP7A promotes angiogenesis by limiting autophagic degradation of VEGFR2

Dipankar Ash et al.

Summary: This study reveals a previously unknown interaction between the Copper transporter ATP7A, autophagy, and VEGFR2 degradation in endothelial cells, highlighting the importance of ATP7A in regulating VEGFR2 signaling and angiogenesis. The findings suggest that ATP7A acts as a potential therapeutic target for ischemic cardiovascular diseases by promoting VEGFR2-mediated angiogenesis and neovascularization.

NATURE COMMUNICATIONS (2021)

Review Immunology

The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity

Zhengguo Wu et al.

Summary: Cancer immunotherapy is a promising treatment to control and eliminate tumors, but it is currently only effective for certain types of tumors and faces challenges. By studying tumor microenvironment immunotherapy, the anti-tumor immunity can be enhanced, improving the effectiveness of immunotherapy.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma

Yuan Yang et al.

Summary: This study constructed a risk model based on five-gene signature by identifying angiogenesis-related immune genes affecting the prognosis of HCC. The model effectively predicted the survival outcome of HCC patients and showed promising clinical prediction value.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biochemistry & Molecular Biology

PLA2G10 facilitates the cell-cycle progression of soft tissue leiomyosarcoma cells at least by elevating cyclin E1/CDK2 expression

Gang Tan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Review Medicine, Research & Experimental

HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer

Ellen C. de Heer et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Physiology

Ion channels in sarcoma: pathophysiology and treatment options

Thiha Aung et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2019)

Article Biochemistry & Molecular Biology

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

Peng Jiang et al.

NATURE MEDICINE (2018)

Editorial Material Oncology

Evolving biological understanding and treatment of sarcomas

Jean-Yves Blay et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Medicine, Research & Experimental

AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma

Minglei Wang et al.

THERANOSTICS (2017)

Review Peripheral Vascular Disease

Tumor angiogenesis and vascular normalization: alternative therapeutic targets

Claire Viallard et al.

ANGIOGENESIS (2017)

Article Health Care Sciences & Services

Time-dependent ROC curve analysis in medical research: current methods and applications

Adina Najwa Kamarudin et al.

BMC MEDICAL RESEARCH METHODOLOGY (2017)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Oncology

Circulating tumor cells in sarcomas: a brief review

Le Chang et al.

MEDICAL ONCOLOGY (2015)

Article Oncology

Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma

M. V. Gammons et al.

BRITISH JOURNAL OF CANCER (2014)

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Article Biochemistry & Molecular Biology

Characterization and identification of PARM-1 as a new potential oncogene

Cyndia Charfi et al.

MOLECULAR CANCER (2013)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Review Biochemistry & Molecular Biology

Immune infiltration in human tumors: a prognostic factor that should not be ignored

F. Pages et al.

ONCOGENE (2010)

Article Oncology

How to build and interpret a nomogram for cancer prognosis

Alexia Iasonos et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Oncology

Cancer statistics, 2007

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2007)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Pharmacology & Pharmacy

Vascular endothelial growth factor and angiogenesis

A Hoeben et al.

PHARMACOLOGICAL REVIEWS (2004)